knowledge -WSS

knowledge

author：explore 2025-09-02 11:47:23 - browse：86

Cheryl Meier had watched clinical trial enrollment announcements for years — but always for her sons’ type 1 diabetes, never for herself. Her OB-GYN had put her on Effexor for her depression 20 years ago, and it worked well enough — she could sleep for the first time in her life, and she no longer cried at every little thing. But it never worked for her dark thoughts.

But then she retired, and then she had time, and then she saw an email — “I guess once your name gets on a list, it’s there,” she said — for an experimental depression drug called zuranolone.

Unlike today’s crowded market of SSRIs, prescribed once and taken for months, years, or even indefinitely, zuranolone, developed by Sage Therapeutics, promises something different.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： ALS advocates say criticism of new drugs misses bigger picture

focus

knowledge

WSS

Listen: More tumult at BIO & coercive care for sickle cell patients

Covid hospitalizations on the rise, Humana says

H5N1 bird flu outbreak: Second human case reported, in Michigan

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Ethical issues complicate the benefits of medical crowdfunding

Trump surgeon general acknowledges mistakes during Covid

focus

knowledge

focus

How one medical school became remarkably diverse

Ethical issues complicate the benefits of medical crowdfunding

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Listen: Biogen's potential pivot, & Illumina's next chapter

Activists slam private health insurers over coverage restrictions

Bird flu surveillance in wastewater gets boost from consortium

In Memoriam: Notable people who died in 2023

Amazon on where the company's health care bets are headed next

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

knowledge

H5N1 virus can be tracked in retail milk, scientists say

Reports of telehealth's death have been greatly exaggerated

What drug price negotiations mean for Medicare Part D

Advances in CAR

Reports of telehealth's death have been greatly exaggerated

UnitedHealth argues against case alleging wrongful AI care denials

entertainment

focus

knowledge

hotspot